Decheng Capital Management III (Cayman), LLC
CIK
1747821
Location
Grand Cayman, E9
Portfolio Value
Small
$178,463,070
Diversification
Diversified
Filing Date
Global Rank
#3,411
/ 6,895
▲ 116
Top Industry
Biotechnology
71.2%
3Y Alpha vs SPY
-22.6%
Period ended 2 years ago
Filed Nov 29, 2023 · 2y
7 quarters · since Mar 2022
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
-5.3%
SPY
+76.3%
Annualised alpha
-22.6%
Max drawdown
−62.8%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
19 positions · as of Sep 30, 2023 · Δ vs Jun 30, 2023Top Position
23.6%
−10.7 pts
Top 5
57.8%
−18.3 pts
Top 10
87.0%
−10.1 pts
HHI
1,050
Diversified−685
Portfolio Trend
7 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2023| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $178,463,070 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| AURA | Aura Biosciences, Inc. | +869,790 | 1,163,123 | $10,433,213 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reducedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarter
7 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd. | 1,459,700 | $17,049,296 | |
| LNTH | Lantheus Holdings, Inc. | 142,196 | $9,879,778 | |
| NBP | NovaBridge Biosciences | 4,166,667 | $5,500,000 | |
| BYSI | BeyondSpring Inc. | 4,958,143 | $3,966,514 | |
| ATRC | AtriCure, Inc. | 46,259 | $2,026,144 | |
| PYXS | Pyxis Oncology, Inc. | 326,810 | $650,351 | |
| WGS | GeneDx Holdings Corp. | 103,604 | $377,118 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
19 positions ·
$178,463,070 total
· as of Sep 30, 2023
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ZNTL |
Zentalis Pharmaceuticals, Inc.
Healthcare
|
Held | 2,099,583 | $42,117,634 | 23.60% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
NEW | 1,459,700 | $17,049,296 | 9.55% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
Held | 869,790 | $15,612,730 | 8.75% | |
| TXG |
10x Genomics, Inc.
Healthcare
|
Held | 359,554 | $14,831,602 | 8.31% | |
| ARGX |
Argenx SE
Healthcare
|
Held | 27,429 | $13,484,919 | 7.56% | |
| PACB |
Pacific Biosciences Of California, Inc.
Healthcare
|
Held | 1,463,872 | $12,223,331 | 6.85% | |
| ILMN |
Illumina, Inc.
Healthcare
|
Held | 80,859 | $10,797,983 | 6.05% | |
| AURA |
Aura Biosciences, Inc.
Healthcare
|
Added | 1,163,123 | $10,433,213 | 5.85% | |
| LNTH |
Lantheus Holdings, Inc.
Healthcare
|
NEW | 142,196 | $9,879,778 | 5.54% | |
| PHAT |
Phathom Pharmaceuticals, Inc.
Healthcare
|
Held | 850,000 | $8,814,500 | 4.94% | |
| NBP |
NovaBridge Biosciences
Healthcare
|
NEW | 4,166,667 | $5,500,000 | 3.08% | |
| BYSI |
BeyondSpring Inc.
Healthcare
|
NEW | 4,958,143 | $3,966,514 | 2.22% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Held | 714,285 | $3,592,853 | 2.01% | |
| EQ |
Equillium, Inc.
Healthcare
|
Held | 4,447,308 | $3,291,007 | 1.84% | |
| WHWK |
Whitehawk Therapeutics, Inc.
Healthcare
|
Held | 526,329 | $2,547,432 | 1.43% | |
| ATRC |
AtriCure, Inc.
Healthcare
|
NEW | 46,259 | $2,026,144 | 1.14% | |
| SCYX |
Scynexis Inc
Healthcare
|
Held | 555,555 | $1,266,665 | 0.71% | |
| PYXS |
Pyxis Oncology, Inc.
Healthcare
|
NEW | 326,810 | $650,351 | 0.36% | |
| WGS |
GeneDx Holdings Corp.
Healthcare
|
NEW | 103,604 | $377,118 | 0.21% |